Backlogs: an ongoing challenge for sleep clinics

Waitlists in sleep centers—in many cases extending 3 to 4 months—have grown considerably longer as a result of the COVID-19 pandemic.1 The sleep community needs solutions now—not only to get through this difficult time, but to help prevent lengthy backlogs in the future.
The COVID-19 Sleep Center Impact Study provides important insights
Home sleep testing—which was increasing at a record-setting pace prior to the pandemic1—has since become an essential tool in sleep medicine.

According to the study of 100 leading sleep medicine professionals1:

The ratio of home sleep testing vs in-lab testing was more than 2 to 11

Home sleep testing: rising to the challenge

Increasing adoption, investment, and availability of at-home greater access to patient care, particularly during crises diagnostics, therapeutic pathways, and clinical management enable greater access to patient care, particularly during crises."

– Covid-19 Sleep Center Impact Study1
  • When the doors of sleep labs were shut, home sleep testing opened the pathway to care for countless patients
  • As pandemic restrictions ease, it can continue its vital role by helping to reduce backlogs caused by limited in-lab capacity and increased demand for sleep testing
WatchPAT® ONE: Looking further than AHI for diagnostic confidence outside the lab

Goes far beyond standard HSAT metrics
Provides comprehensive sleep data that can facilitate an accurate diagnosis, including:

  • Central and obstructive sleep apnea differentiation
    Identifies central sleep apnea and percent of sleep time with Cheyne-Stokes respiration

  • Sleep-stage detection
    Powered by breakthrough PAT® technology that can detect sleep stages and REM sleep apnea

  • True sleep time metrics
    Uses advanced actigraphy that differentiates between wake and sleep periods so true sleep time is used to calculate AHI and RDI

  • Insomnia assessment
    Supported by an advanced mobile app with an in-app questionnaire that evaluates insomnia, as well as daytime sleepiness, sleep scheduling, and more

Fast, easy to use, and highly accurate2

  • Fully disposable to reduce infection risks
  • Instant* results via the cloud
  • Technology that has been clinically validated vs PSG2

Ready to expedite and expand sleep apnea care?

Just complete the form below, and we’ll be in touch!


*Within minutes of test completion.

References: 1. Ensodata. COVID-19 Sleep Center Impact Study. Accessed July 11, 2021. 2. Yalamanchali S, Farajian V, Hamilton C, Pott TR, Samuelson CG, Friedman M. Diagnosis of obstructive sleep apnea by peripheral arterial tonometry: meta-analysis. JAMA Otolaryngol Head Neck Surg. 2013;139(12):1343-1350. doi:10.1001/jamaoto.2013.5338. 

This material is subject to a disclaimer available here.

Your information will be handled in accordance with our privacy policy.

When using the marks in our publications and this website, we used the appropriate ™, ℠, or ®. The ® symbol is used to indicate registrations in the U.S. and the territories listed in and this should not mean that such trademarks are necessarily registered in other countries. For example, WatchPAT®  is a trademark of Itamar Medical Ltd., registered in the U.S. and the applicable territories listed in only.

Copyright © 2022 Itamar Medical Ltd.  All rights reserved. WatchPAT and PAT are trademarks or registered trademarks of Itamar Medical Ltd., a subsidiary of ZOLL Medical Corporation, in the United States and/or other countries. All other trademarks are the property of their respective owners.